When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GWPH - Kalytera Is Set To Become The Next GW Pharma After Groundbreaking Phase 2 Trial Results
GW Pharmaceuticals Plc
About a month ago I wrote an article summarizing the investment opportunities and risks with Kalytera Therapeutics, Inc. (KALTF) (KLY.V). Since then, the company has released stunning Phase 2 clinical study data evaluating cannabidiol, or CBD, for the prevention of acute graft versus host disease. This "miracle cure" for GVHD positions Kalytera to become the next GW Pharmaceuticals (GWPH). GWPH has a market cap of close to $5 billion while KALTF has a market cap over 200 times smaller at just $20 million. So it goes without saying that Kalytera has